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Abstract
Cyclin J is a cyclin family member that appears to have evolved before the metazoan radiation. Its
evolutionary conservation argues for an important role but functional characterizations of Cyclin J have
remained very limited. In Drosophila, Cyclin J is expressed only in females. Using transgenic
Drosophila lines expressing Cyclin J versions with N- or C-terminal GFP extensions, we demonstrate
that it is expressed exclusively in the germline. After low level expression in all nuclei within the
germarium, it gets highly enriched in the germinal vesicle within the oocyte until stage 12 of oogenesis,
followed by disappearance after germinal vesicle breakdown before the first meiotic division.
Surprisingly, Cyclin J is not required for female fertility. Chromosome segregation during female
meiosis, as well as the rapid early embryonic cell cycles after fertilization, occurs normally in the
complete absence of Cyclin J. Cyclin J with EGFP fused at either N- or C-terminus binds to Cdk1 and
not to Cdk2. However, in contrast to the other known Cdk1 partners, the A- and B-type cyclins, Cyclin J
is not degraded during mitosis.
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Abstract 
Cyclin J is a cyclin family member that appears to have evolved before the metazoan 
radiation. Its evolutionary conservation argues for an important role but functional 
characterizations of Cyclin J have remained very limited. In Drosophila, Cyclin J is expressed 
only in females. Using transgenic Drosophila lines expressing Cyclin J versions with N- or C-
terminal GFP extensions, we demonstrate that it is expressed exclusively in the germline. 
After low level expression in all nuclei within the germarium, it gets highly enriched in the 
germinal vesicle within the oocyte until stage 12 of oogenesis, followed by disappearance 
after germinal vesicle breakdown before the first meiotic division. Surprisingly, Cyclin J is 
not required for female fertility. Chromosome segregation during female meiosis, as well as 
the rapid early embryonic cell cycles after fertilization, occurs normally in the complete 
absence of Cyclin J. Cyclin J with EGFP fused at either N- or C terminus binds to Cdk1 and 
not to Cdk2. However, in contrast to the other known Cdk1 partners, the A- and B-type 
cyclins, Cyclin J is not degraded during mitosis.  
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Introduction 
The first cyclin proteins were identified because of their rapid and complete disappearance 
during the early cleavage divisions in invertebrate embryos (Evans et al., 1983). Additional 
members of this eukaryotic protein family were subsequently identified and shown to function 
as regulatory subunits that associate with Cyclin-dependent protein kinases (Cdks) (Morgan, 
2007). Various Cyclin-Cdk complexes are involved in the control of progression through the 
cell cycle or in other fundamental cellular processes like transcription. The originally 
described, rapid proteolysis during mitosis is only observed for the so-called mitotic cyclins. 
Based on sequence comparisons these cyclins have also been classified as A- and B-type 
cyclins. In Drosophila, as in other animal species, the mitotic cyclins bind to Cdk1 (Knoblich 
et al., 1994). The Cdk1 complexes are of special importance for the control of progression 
through mitosis. Activation of Cdk1 which depends on complex formation with mitotic 
cyclins results in entry into mitosis and transforms the cellular organization from interphase to 
metaphase architecture. Progression into anaphase and exit from mitosis requires inactivation 
of Cdk1 which results from ubiquitin-dependent degradation of the mitotic cyclins after 
activation of the Anaphase-Promoting Complex/Cyclosome (APC/C) ubiquitin ligase (Peters, 
2006). 
   Cdk2 is involved in the control of progression into S phase (Woo and Poon, 2003). In 
mammalian cells, Cdk2 associates with A- and E-type cyclins. In Drosophila, Cyclin A-Cdk2 
complexes have not been observed, while Cyclin E-Cdk2 complexes are clearly present in 
vivo (Knoblich et al., 1994; Meyer et al., 2000). This apparent difference might have evolved 
in the context of diversification of regulatory mechanisms controlling mitotic and 
endoreduplication cycles, respectively. While endoreduplication normally occurs only in very 
few cell types in mammals, this form of genome amplification by periodic S phases without 
intervening mitoses is extensively exploited during development and adult life of Drosophila 
melanogaster and many other organisms (Edgar and Orr-Weaver, 2001). Drosophila Cyclin E 
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and Cyclin A can both trigger entry into S phase (Knoblich et al., 1994; Sprenger et al., 1997) 
and at the same time contribute to a block to re-replication (Follette et al., 1998; Sauer et al., 
1995; Weiss et al., 1998). While this blocking effect is eliminated by mitotic degradation in 
case of Cyclin A, Cyclin E degradation is not coupled to mitosis and involves different 
pathways (Hwang and Clurman, 2005; Sauer et al., 1995). In D. melanogaster, Cyclin E 
might therefore have been selected as the unique Cdk2 regulator that works for S phase 
regulation in both mitotic and endocycles.  
   In contrast to A-, B- and E-type cyclins, the role of Cyclin J has not yet been characterized 
in detail. Cyclin J was originally identified in a yeast two hybrid screen for Drosophila 
proteins that interact with Drosophila Cdk1/Cdc2 and Cdk2/Cdc2c (Finley Jr. et al., 1996). 
Cyclin J mRNA and protein were detected exclusively during oogenesis and early 
embryogenesis (Kolonin and Finley, 2000). Microinjection of antibodies against Cyclin J as 
well as aptamers into early Drosophila embryos was reported to cause severe mitotic defects. 
These findings are consistent with the idea that Cyclin J provides a function specifically 
required during the special early cycles at the start of Drosophila embryogenesis where 
progression through the cell cycle is extremely rapid, omitting gap phases and cytokinesis.  
   Based on its expression pattern, Cyclin J might also function during oogenesis. Drosophila 
oogenesis starts with an asymmetric division of germline stem cells at the distal end of an 
ovariole (for a detailed description of oogenesis see Spradling, 1993). The differentiating 
daughter cell, progresses through four cell division cycles with incomplete cytokinesis 
resulting in 16-cell clusters interconnected by ring canals. Fifteen cells of the cluster develop 
into nurse cells and one into an oocyte. The oocyte enters meiosis and remains arrested in a 
special diplotene stage with the chromatin compacted into a karyosome for most of oogenesis. 
The nurse cells progress through several endoreduplication cycles. Egg chambers are 
completed by the formation of an enveloping epithelial layer of somatic follicle cells at the 
proximal end of the germarium. During their travel from the distal germarium to the proximal 
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end of the ovariole, egg chambers progress through 14 stages during which the oocyte 
acquires abundant maternal stores as well as an egg shell. During stage 13, fully grown 
oocytes enter into the first meiotic division. After germinal vesicle breakdown and spindle 
formation, they arrest in metaphase of meiosis I in stage 14. Completion of meiosis occurs 
only after egg activation which is triggered by egg laying.  
   To evaluate whether Drosophila Cyclin J might function already during oogenesis, we have 
generated Drosophila females that completely lack this cyclin. Surprisingly, their fertility was 
found to be normal. Our genetic characterization demonstrates therefore that Cyclin J is not 
required for progression through the mitotic cycles of the germline cells at the start of 
oogenesis. Moreover, it is entirely dispensable for meiosis and the syncytial cycles at the 
onset of embryogenesis. Like the Drosophila A- and B-type cyclins, Cyclin J appears to 
associate with Cdk1 and not with Cdk2. But in contrast to the other Cdk1 partners this 
unusual cyclin is not degraded during mitosis. 
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Materials and Methods 
Fly strains and genetics 
P{wHy}CycJDG29702, PBac{5HPw+}CycJA138 and Df(3L)Exel6095 which deletes CycJ were 
obtained from the Bloomington Drosophila Stock Center at Indiana University. 
PBac{RB}e01160 and PBac{XP}d07385 were obtained from the Exelixis Collection at the 
Harvard Medical School and used for the generation of Df(3L)AJ14/TM3, Ser as described by 
(Parks et al., 2004; Thibault et al., 2004). CycE01672 (Lilly and Spradling, 1996) was kindly 
provided by Mary Lilly (NIH, Bethesda, MD, USA). The lines with CycAC8LR1 (Sigrist and 
Lehner, 1997), CycAneo114 (Lehner and O'Farrell, 1989), CycB2, CycB3, CycB33 (Jacobs et al., 
1998), CycEAR95, Cycpz5 (Knoblich et al., 1994), P{prd-GAL4} (Brand and Perrimon, 1993), 
P{matα4-GAL-VP16}V2H (Hacker and Perrimon, 1998), P{UAS-Cdk1-myc}III.1 or P{UAS-
Cdk2-myc}III.2 (Meyer et al., 2000) or with two gEGFP-Mps1 transgene insertions (II.1 and 
II.2) resulting in expression of EGFP-Mps1 under control of the Mps1 cis-regulatory region 
(Fischer et al., 2004) have been described. Lines with the transgenes gCycJ, gEGFP-CycJ, 
gCycJ-EGFP, UAS-EGFP-CycJ, UAS-CycJ-EGFP, gcal1-EGFP, garmi, or gCG14971 were 
obtained after P element-mediated germline transformation with the constructs described 
below. Selected transgene insertions were combined with Df(3L)AJ14 by meiotic 
recombination. Df(3L)AJ14, garmi III.8, gCG14971 III.10 can be kept as a homozygous 
stock. The presence or absence of various genes on the original Df(3L)AJ14 chromosome and 
its derivatives was confirmed by PCR assays using the following gene-specific primer pairs: 
IV35 (5'-CGATGGTGGTTCCAAGACC-3') and IV36 (5'-GCCTGGTCTATTGATCATCG-
3') for an eIF5B fragment, IV37 (5'-CGAGCAGCACTATTCATTCC-3') and IV38 (5'-
GGAATGTTCTCCGCTTCACC-3') for an armi fragment, IV39 (5'-
GTCGCGTCGCTTCAGCACG-3') and IV40 (5'-TTTCGCGCAGTTCATAATGCAG-3') for 
an CG14971 fragment, AF22 (5'-CCTGGCTAAGACGCACTGG-3') and AF23 (5'-
GCTATATGAAGACAAGTGATGG-3') for a CycJ fragment, XP5 (5'-
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AATGATTCGCAGTGGAAGGCT-3') and RB3 (5'-TGCATTTGCCTTTCGCCTTAT-3') for 
the amplification of the XP-RB hybrid transposon. 
   C(1;Y), y1 v1 f1 B1: y+/C(1)RM, y2 su(wa)1 wa flies were kindly provided by Terry Orr-
Weaver (Whitehead Institute for Biomedical Research, Cambridge, MA, USA). Males from 
this stock were used for the analysis of X chromosome non-disjunction during meiosis in 
oocytes as described (Kerrebrock et al., 1992). The different genotypes of the females 
analyzed were w1 (for control), or P{wHy}CycJDG29702, or +/+; Df(3L)AJ14, garmi III.8, 
gCG14971 III.10, or gCycJ II.41/+; Df(3L)AJ14, garmi III.8, gCG14971 III.10. For these 
genotypes, the corrected total X non-disjunction rate (Kerrebrock et al., 1992) determined 
from more than 1300 progeny was found to be 0.22%, 1.07%, 0.41% and 0.44%, respectively. 
   For our analysis of genetic interactions between CycJ and CycE, we crossed virgin females 
of the genotype Df(3L)AJ14, garmi III.8, gCG14971 III.1/Df(3L)AJ14 (CycJ-deficient), or 
CycE01672 (CycE hypomorph), or CycE01672; Df(3L)AJ14, garmi III.8, gCG14971 
III.1/Df(3L)AJ14 (double mutant) with w1 males and counted the number of progeny which 
was found to be 440 (+/- 40 s.d, n = 3), 135 (+/- 11 s.d, n = 3) and 127 (+/- 34 s.d, n = 2) with 
CycJ-deficient, CycE hypomorph and double mutant females, respectively. Genotypes and 
results of the experiments addressing genetic interaction between CycJ and CycA, CycB and 
CycB3 are provided in Supplementary Figure 1. 
 
Plasmid constructions 
The DNA fragments used for the CycJ, armi and CG14971 transgene constructs were derived 
from the BACR09B04 clone (Hoskins et al., 2000). A 5 kb BglII fragment including most of 
armi was subcloned into BamH1 and BglII cut pSLfa1180, resulting in cloning intermediate 1. 
A neighbouring 4 kb BglII fragment with the remainder of armi, CycJ and a small part of 
CG14971 was subcloned into BglII cut pLitmus28, resulting in intermediate 2. The rest of 
CG14971 was enzymatically amplified using the primer pair IV5 (5'- 
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CAATGGCCCAAGTTATCTCATTCG-3') and IV6 (5'-CCA GGCGGCCGC 
ACTCTGACAACTTTTTGGTGCG-3') introducing a NotI site. The resulting PCR product 
was cut with BglII and NotI and inserted into the corresponding sites within the intermediate 
1, resulting in intermediate 3. The CycJ gene was deleted from intermediate 2 with an inverse 
PCR with the primer pair IV3 (5'-CCGA GCGGCCGC ACCCATTGAAACACGCC-3') and 
IV4 (5'-CGAA GCGGCCGC AGCAGCGTTCCCAGAC-3') followed by digestion with NotI 
and re-ligation, resulting in the intermediate 4. The BglII fragment from the intermediate 4 
was subsequently inserted into the BglII site within the intermediate 3, resulting in 
intermediate 6. To arrive at the garmi construct, we first transferred a 2.2 kb SalI-XbaI 
fragment with the 5' region of armi from intermediate 6 into XhoI and XbaI cut pCaSpeR4, 
resulting in intermediate 7. The construct was completed by transposing a 3.8 kb XbaI-NotI 
fragment with the 3' region of armi from intermediate 6 into the corresponding sites of 
intermediate 7. To arrive at the gCG14971 construct, we transposed a 4.2 kb Not I fragment 
from intermediate 6 into the NotI site of pCaSpeR4. The gCycJ construct was obtained by 
inserting the 4 kb BglII fragment from intermediate 2 into the BamHI site of pCaSpeR4. For 
the gEGFP-CycJ construct, we first subcloned a 0.5 kb Sal1 fragment including the 
translational start site from intermediate 2 into the corresponding site of pBluescript KS+ 
followed by introduction of an NheI site at the translational start of CycJ by inverse PCR 
using the primer pair IV48 (5'-GGCG GCTAGC ATGGAGCAGAAAGTGGCTGCC -3') and 
IV49 (5'-GGAG GCTAGC TGTATCGAAATTGAATGCAATGCC-3'). After inserting the 
EGFP coding sequence as an XbaI fragment into this newly created site, the modified SalI 
fragment containing the EGFP sequence was used to replace the original SalI fragment in 
intermediate 2, followed by transposition of the BglII fragment into the BamHI site of 
pCaSpeR4. For the gCycJ-EGFP construct, an NheI site was introduced into intermediate 2 
immediately upstream of the translational stop of CycJ by inverse PCR using the primer pair 
IV50 (5'-GGCG GCTAGC TAGTAAAAGGGAAAAACGAAACTATTAC -3') and IV51 (5'-
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GAGG GCTAGC ATCTTTGGCTACACTCTCCACTTTG-3'). After insertion of the EGFP 
coding sequence as an XbaI fragment into this newly created site, the BglII fragment was 
transposed in the BamHI site of pCaSpeR4 These constructs for CycJ expression without or 
with EGFP at either N- or C terminus under control of the genomic CycJ cis-regulatory region 
contain the complete intergenic regions up- and downstream from CycJ as well as the 
genomic 5' and 3' UTRs.  
   The pUAST-EGFP-CycJ construct was obtained by enzymatic amplification of the CycJ 
sequence from the gEGFP-CycJ construct with the primer pair JoK10 (5'-AGCTGTAC 
GCGGCCGC CATGGAGCAGAAAGTGGC-3') and JoK11 (5'-TTTTCC GGTACC 
CTAATCTTTGGCTACACTCTC-3') which introduced flanking NotI and KpnI sites, 
respectively. After digestions with these enzymes, the PCR fragment was transposed into the 
corresponding sites within pUAST-EGFP-MCS (Schittenhelm et al., 2007). The pUAST-CycJ-
EGFP construct was obtained by amplification of the CycJ sequence from the gEGFP-CycJ 
construct with the primer pair JoK10 and JoK12 (5'-TCCCTT GGTACC 
ATCTTTGGCTACACTCTCCAC-3') which also introduced flanking NotI and KpnI sites, 
respectively. After digestions with these enzymes, the PCR fragment was transposed into the 
corresponding sites within pUAST-MCS-EGFP (Schittenhelm et al., 2007). The CycJ region 
in pUAST-EGFP-CycJ and pUAST-CycJ-EGFP was completely sequenced and found to be 
correct.  
 
Sequence comparisons 
The cyclin tree (Fig. 1) was constructed using the on-line version of T-REX (Makarenkov, 
2001); www.trex.uqam.ca) based on a Clustal W alignment for which only cyclin box regions 
without N-terminal extensions were used in case of A-, B- and E-type cyclins. The J-type 
cyclins do not have an N-terminal extension preceding the cyclin box region. Accession 
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numbers of the used cyclin J sequences are NP_061957.2, AAH35871.3, NP_766427.1, 
NP_001038995.1, NP_523903.1, XP_001641369.1, XP_001237463.2, EDQ87852.1. 
 
Immunoprecipitation, immunoblotting and immunofluorescence 
Oocytes for immunoprecipitation experiments were mass isolated (Page and Orr-Weaver, 
1997) from gCycJ-EGFP II.6, or gEGFP-CycJ III.16, or gcal1-EGFP II.1, or gEGFP-Mps1 
II.1, II.2 females before extract preparation. Embryos were collected for 3 hours on apple agar 
plates from crosses of UAS-Cdk1-myc III.1, UAS-Cdk2-myc III.2 males with females, which 
were either matα4-GAL-VP16/CyO or matα4-GAL-VP16, UAS-EGFP-CycJ II.1/CyO or 
matα4-GAL-VP16, UAS-CycJ-EGFP II.2/CyO, and aged for 3 hours at 25°C. 
Immunoprecipitation from native oocyte and embryo extracts as well as protein identification 
by mass spectroscopy was done essentially as described (Schittenhelm et al., 2007) using 
affinity-purified rabbit antibodies against GFP (IS28) in combination with Protein-A-
Sepharose beads (Affi-Prep, Biorad). The proteins immunoprecipitated from either ovary or 
embryo extracts which were analyzed by immunoblotting (Fig. 4 A or C, respectively) were 
isolated using an amount of extract which was 16 or 80 times more, respectively, than the 
amount of extract loaded for parallel analysis.  
   For immunoblotting, oocytes were mass isolated from gCycJ-EGFP II.6 females before 
fixation in a 1:1 mixture of methanol and heptane. Fixed oocytes were transferred to a 1:1 
mixture of glycerol and EB buffer (Edgar et al., 1994). After DNA labelling with Hoechst 
33258 (1 μg/ml), oocytes were sorted according to their developmental stage with an inverted 
fluorescence microscope.  
   Immunoblots were probed with affinity-purified rabbit antibodies against GFP (IS28) at a 
dilution of 1:3000, affinity-purified rabbit antibodies against Cdk2 at 1:4000, mouse 
monoclonal antibodies against GFP (Roche) at 1:500, a mouse monoclonal antibody against a 
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PSTAIR peptide (SIGMA, P7962) at 1:50000 and a mouse monoclonal antibody against a 
human myc peptide (9E10) at 1:15. 
   For fluorescence microscopy, ovaries were dissected from gEGFP-CycJ III.6 females as 
described (Page and Hawley, 2001). Oocytes were fixed for 20 minutes in 2% 
paraformaldehyde in phosphate buffered saline containing 0.5% Nonidet-P40. After DNA 
labelling with Hoechst 33258 (1 μg/ml), ovaries were analyzed with an Olympus FluoView 
1000 laser scanning confocal microscope. For immunofluorescent labeling of embryos, we 
collected eggs for 1 hour on apple agar plates and aged at 25°C. Eggs were collected from a 
cross of CycAC8LR1, prd-GAL4/TM3, Sb P{35UZ}2 females with UAS-CycJ-EGFP II; 
CycAC8LR1/TM3, Ser males and aged for 7 hours. Eggs were also collected from a cross of 
Df(3L)AJ14, garmiIII.8, gCG14971 III.10/Df(3L)AJ14 females with w1 males and aged for 1 
hour. Embryos were fixed essentially as described previously (Karr and Alberts, 1986). For 
immunofluorescent labeling we used mouse monoclonal antibody DM1A anti-α-tubulin 
(Sigma) at 1:8000, rabbit serum against Drosophila Cyclin A at 1:3000. Secondary antibodies 
were Cy5-conjugated goat antibodies against mouse IgG (Jackson Immunochemicals) and 
Alexa 568-conjugated goat antibodies against rabbit IgG (Molecular Probes). For the DNA 
staining of embryos, we also used Hoechst 33258 at 1 μg/ml. Embryos were analyzed with a 
Zeiss Cell Observer HS wide field fluorescence microscope.  
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Results 
Cyclin J has evolved before the metazoan radiation 
When originally identified in Drosophila (Finley Jr et al., 1996), Cyclin J did not appear to 
have homologs in other species. However, subsequent additions to Genbank have revealed 
that this cyclin type is not restricted to Drosophila. While not recognizable in plant genomes 
(Guo et al., 2007; Wang et al., 2004), Cyclin J homologs are present throughout the metazoan 
radiation (Fig. 1, data not shown). In the mammalian lineage, paralogous cyclin J genes 
(Cyclin J and Cyclin J-like) are apparent, as also in case of the better-characterized A-, B-, D- 
and E-type cyclins. In contrast, only single orthologs for each of these cyclin types including 
Cyclin J are present in the Drosophila genome. Importantly, a cyclin J homolog can also be 
identified in Monosiga brevicollis, a member of the choanoflagellates which are considered to 
be the closest unicellular relatives of metazoans.  
 
The pattern of Cyclin J expression revealed by EGFP fusion transgenes 
Cyclin J has evolved before the specialized syncytial cycles characteristic of early insect 
embryogenesis. Consistent with the known expression pattern (Finley Jr. et al., 1996; Kolonin 
et al., 2000), it might therefore have functions already during oogenesis and not just during 
the syncytial cycles where it has been characterized functionally so far. For a more detailed 
analysis of Cyclin J expression during oogenesis, we generated transgenic lines expressing 
Cyclin J fused to EGFP either at the N- or the C-terminus under the control of the genomic 
Cyclin J regulatory sequences. The results obtained with multiple gEGFP-CycJ and gCycJ-
EGFP lines were essentially identical (Fig. 2 and data not shown).  
   EGFP-Cyclin J signals above background were detected in the germarium at the distal end 
of ovarioles. Based on the EGFP pattern in the germarium, all germline cells appeared to be 
weakly positive in contrast to somatic cells (Fig. 2C-E). In the newly formed egg chambers at 
stage 1 of oogenesis, the peripheral somatic follicle cells did definitely not display EGFP 
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fluorescence, while the germ line derivatives in the interior were positive (Fig. 2C-E). Signals 
in the oocyte were stronger than in the nurse cells. All signals were nuclear. In the oocyte, 
EGFP-Cyclin J was observed throughout the germinal vesicle, whereas the condensed DNA 
was restricted to the compact karyosome (Fig. 2I-K). After germinal vesicle break down 
during stage 13, we were unable to detect signals that were clearly above the uniform 
substantial background fluorescence (Fig. 2L-N). Similarly, after egg deposition and 
fertilization, we were unable to detect signals that were clearly above background (data not 
shown).  
   For further clarification whether Cyclin J is still present in oocytes after germinal vesicle 
breakdown, we performed immunoblotting experiments. Egg chambers were sorted 
microscopically before extract preparation. In extracts prepared from stage 12 egg chambers 
(i.e. before germinal vesicle breakdown) Cyclin J-EGFP was clearly detectable by 
immunoblotting with antibodies against GFP (Fig. 3, lane 3), as expected from the observed 
pattern of EGFP fluorescence in ovaries (Fig. 2). However, in extracts prepared from stage 14 
egg chambers, Cyclin J-EGFP was essentially no longer detectable (Fig. 3, lane 4). Similar 
observations (data not shown) were made with extracts from females expressing EGFP-Cyclin 
J, although expression levels on average appeared somewhat lower with gCycJ-EGFP lines in 
comparison to gEGFP-CycJ lines. In extracts prepared from early embryos collected from 
females with either a gEGFP-CycJ or a gCycJ-EGFP transgene, we were also unable to detect 
the EGFP tagged Cyclin J variants (data not shown). We conclude therefore that the levels of 
Cyclin J fused to EGFP decrease during the final stages of oogenesis following germinal 
vesicle breakdown.  
 
Cyclin J binds to Cdk1 
To identify proteins that associate with Cyclin J we immunoprecipitated CycJ-EGFP from 
extracts prepared from ovaries of gCycJ-EGFP females. In control experiments, we used the 
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same affinity-purified antibodies against EGFP for immunoprecipitation of Cal1-EGFP from 
extracts prepared from ovaries of gcal1-EGFP females. MS/MS analysis was used to identify 
co-immunoprecipitated proteins. Among the proteins which were specifically co-
immunoprecipitated with CycJ-EGFP, we clearly detected Cdk1 but not Cdk2 
(Supplementary Table 1). Immunoblot analyses confirmed that Cdk1 but not Cdk2 was co-
immunoprecipitated with CycJ-EGFP (Fig. 4A). Moreover, in a similar experiment using 
EGFP-Mps1 as a control, we also observed co-immunoprecipitation of Cdk1 but not Cdk2 
with N-terminally EGFP tagged CycJ in immunoblot and MS/MS analyses (data not shown).  
   Cdk1 and Cdk2 expression levels appear to be comparable (Karsten Sauer and C.F.L., 
unpublished information) and both have been readily detected by shot gun proteomics 
(Brunner et al., 2007). Therefore, the observation that Cdk1 was co-immunoprecipitated by 
both EGFP-CycJ and CycJ-EGFP from ovary extracts strongly suggested that Cyclin J prefers 
Cdk1 over Cdk2 as partner kinase. To confirm this partner preference and circumvent the 
limited detection sensitivity resulting from the low expression of transgenes driven by the 
CycJ cis-regulatory region we performed experiments after overexpression in embryos. 
Overexpression of EGFP-Cyclin J during the embryonic cell division cycles was achieved 
with an appropriate UAS transgene inherited from the father in combination with maternally 
expressed matα4-GAL-VP16. Moreover, in addition to UAS-EGFP-CycJ, we simultaneously 
expressed UAS-Cdk1-myc and UAS-Cdk2-myc. The simultaneous overexpression of EGFP-
Cyclin J, Cdk1-myc and Cdk2-myc did not noticeably affect embryonic development (data 
not shown). Immunoblotting experiments with embryonic extracts and anti-myc antibodies 
clearly demonstrated that Cdk1-myc and Cdk2-myc can be identified unambiguously even 
after co-expression because of their distinct electrophoretic mobility (Fig. 4B). 
Immunoblotting with anti-myc also demonstrated that Cdk1-myc and Cdk2-myc were 
expressed at comparable levels (Fig. 4B, data not shown). However, after 
immunoprecipitation with anti-EGFP, we observed only Cdk1-myc and not Cdk2-myc in the 
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EGFP-Cyclin J immunoprecipitates (Fig. 4C). Moreover, we also detected the endogenous 
untagged Cdk1 in the EGFP-Cyclin J immunoprecipitates while Cdk2 was not detectable (Fig. 
4C). These results strongly support the notion that Cyclin J associates specifically with Cdk1. 
 
Cyclin J-EGFP is not degraded during M phase  
The known Drosophila Cdk1 partner cyclins, the A- and B-type cyclins, become rapidly 
degraded during mitosis (Lehner and O'Farrell, 1990). In the germarium, therefore, these 
mitotic cyclins are absent from cells in late mitosis and early G1 (Hatfield et al., 2005; Wang 
and Lin, 2005). Our observation that EGFP-Cyclin J and Cyclin J-EGFP was present at 
comparable levels in all germline cells within the germarium suggested that Cyclin J is not 
degraded during mitosis. To evaluate the behavior of Cyclin J during mitosis, we used the 
UAS/GAL4 system to drive its expression during embryogenesis. The developmentally 
controlled, highly reproducible division programme of embryogenesis facilitates careful 
analyses. We used prd-GAL4 to drive expression of Cyclin J-EGFP (Fig. 5) or EGFP-Cyclin J 
(data not shown) in alternating epidermal stripes. Embryos were fixed at the stage of mitosis 
16. Progression through mitosis 16 occurs earlier in the dorsal epidermis than in the ventral 
epidermis. After fixation at the stage of mitosis 16, cells in the dorsal epidermis in many 
embryos are already in G1 of cycle 17 while the cells in the ventral epidermis are still in G2 
before mitosis 16. As each embryonic division partitions the embryo into progressively 
smaller cells, the nuclear density revealed by DNA staining in such embryos is twice as high 
in the dorsal epidermis in comparison to the ventral epidermis (Fig. 5C,F). Moreover, as 
previously described, the A- and B-type cyclins are degraded in mitosis 16 and remain 
unstable during G1 of cycle 17 (Sigrist and Lehner, 1997). Therefore, anti-Cyclin A labeling 
is absent from the dorsal epidermal cells and, conversely, present in the cytoplasm of ventral 
epidermal cells in such embryos (Fig. 5A,D). However, Cyclin J-EGFP fluorescence in the 
expressing epidermal stripes was not decreased in the dorsal G1 region compared to the 
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ventral G2 region (Fig. 5D). These observations indicate that Cyclin J is an unusual Cdk1 
partner. In contrast to the other Cdk1 partners, i.e. the A- and B-type cyclins, Cyclin J does 
not appear to become degraded during mitosis. The absence of D- and KEN boxes from the 
predicted Cyclin J amino acid sequence further supports this notion. These sequence motifs 
are known to mediate the APC/C-dependent polyubiquitylation and consequential 
proteasomal degradation of A- and B-type cyclins during M and G1 phases (Peters, 2006).   
   prd-GAL4 driven UAS-CycJ-EGFP expression in CycA mutant embryos allowed us also to 
address whether Cyclin J might be able to replace Cyclin A functionally. We have previously 
demonstrated that the failure of epidermal cells to progress beyond G2 of cycle 16 which is 
caused by a loss of zygotic CycA function is readily prevented by prd-GAL4 driven UAS-
CycA expression (Reber et al., 2006). However, this premature cell cycle arrest in G2 before 
mitosis 16 in CycA mutants (Fig. 5G-I) was not prevented by analogous Cyclin J-EGFP 
expression (Fig. 5J-L). In both, CycA mutants and sibling embryos, we observed the same 
results after prd-GAL4 driven expression of either UAS-CycJ-EGFP (Fig. 5) or UAS-EGFP-
CycJ (data not shown).  
 
Cyclin J is not required for oogenesis and early embryonic development  
To address the function of Cyclin J, we generated lines completely lacking the CycJ gene. 
Transposon insertions carrying FRT sites allowed a Flp recombinase-mediated isolation of an 
11 kb chromosomal deletion, Df(3L)AJ14, removing CycJ and the flanking genes armitage 
(armi) and CG14971 (Fig. 6A). Characterization of the Df(3L)AJ14 chromosome by PCR 
confirmed the presence of the expected deletion (Fig. 6B). To restore the function of the 
flanking genes, we introduced transgenes (garmi and gCG14971) carrying genomic fragments 
including armi and CG14971, respectively, by P element-mediated germline transformation 
and recombined insertions with Df(3L)AJ14. 
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   Initial analyses revealed that homozygous Df(3L)AJ14 progeny from heterozygous parents 
eclosed as adults. The frequency of these adults in comparison to heterozygous siblings 
(Table 1) indicated that the genes CycJ, armi and CG14971 are completely dispensable for 
development to the adult stage. We also obtained normal numbers of adults homozygous for 
Df(3L)AJ14 which had in addition either one or the other or both transgene insertions (garmi 
III.8 and gCG14971 III.10). These transgene insertions therefore do no disrupt gene functions 
required for development to the adult stage.  
   Subsequent analysis of flies lacking one or several of the genes CycJ, armi and CG14971 
indicated that armi but not the other genes are required for normal fertility (Table 1). armi 
encodes a putative RNA helicase involved in the RNA interference pathway and is known to 
be required for normal fertility (Cook et al., 2004). Females without the armi gene did not 
produce eggs and males had a reduced fertility (Table 1). The armi null phenotype therefore 
might be more severe than the phenotypes observed previously with partial loss of function 
alleles which result in abnormally patterned eggs in reduced numbers (Cook et al., 2004). 
CG14971 is an uncharacterized gene which appears to encode a ubiquitously expressed 
member of the solute carrier protein family. 
   Our conclusion that CycJ is not required for viability and fertility was further supported by 
our characterization of a recently isolated transposon insertion P{wHy}CycJDG29702 (Huet et 
al., 2002). Our sequence analysis of a PCR fragment confirmed that this insertion disrupts the 
CycJ coding sequence after the second codon. Therefore the insertion is likely to cause a 
complete loss of CycJ function. Flies homozygous or hemizygous for this insertion eclosed in 
normal numbers and were found to be fully fertile (Table 1). The same findings (data not 
shown) were also observed with flies hemizygous for PBac{5HPw+}CycJA138, a transposon 
insertion which we also confirmed to reside in the first intron and therefore might not 
necessarily impair CycJ gene function. 
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   To evaluate whether loss of CycJ might result in more subtle defects during the syncytial 
cycles of early embryogenesis, we collected eggs from CycJ-deficient females (Fig. 6C) and 
analyzed the frequency and appearance of mitotic figures after fixation and DNA staining. 
However, apart from rare abnormalities, which were also observed to the same extent in 
control collections, defects were not apparent (Fig.6D). Similarly, we failed to detect an 
increased rate of X chromosome non-disjunction during meiosis in CycJ-deficient females 
(see Materials and Methods). A double mutant analysis confirmed that Cyclin J is unlikely to 
have substantial functional overlap with Cyclin E. The reduced fertility of females 
homozygous for the hypomorphic mutation CycE01672 (Lilly and Spradling, 1996) was 
marginally enhanced in double mutants lacking CycJ function completely (see Materials and 
Methods). Moreover, additional attempts to detect potential genetic interactions between CycJ 
and CycA, CycB, CycB3 or CycE equally failed to reveal clear evidence for functional 
redundancies (Supplementary Figure 1). CycJ-deficient females with only one functional gene 
copy of CycA, CycB, CycB3 or CycE had a very similar fertility as those with two functional 
copies. In addition, progression through the syncytial cycles was not compromised by 
reducing the number of functional copies of these other cyclin genes in CycJ-deficient 
mothers.  
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Discussion 
Sequence comparisons demonstrate that Cyclin J is an evolutionary conserved cyclin family 
member. Cyclin J homologs are present throughout the metazoan radiation, as well as in their 
unicellular sister group. While this evolutionary conservation points to an important role of 
Cyclin J, its functional characterization has remained very limited. Moreover, our analyses 
contradict previous conclusions and reveal a number of unexpected findings. Using transgenic 
Drosophila lines expressing Cyclin J versions with N- or C-terminal GFP extensions, we 
demonstrate that it binds to Cdk1 and not to Cdk2. However, in contrast to the other known 
Cdk1 partners, the A- and B-type cyclins, Cyclin J does not appear to become proteolysed 
during mitosis. In addition, its expression pattern is far more restricted. While A- and B-type 
cyclin expression is observed in all mitotically proliferating and meiotic cells, Cyclin J is only 
expressed in the female germ line. While initially present at low levels in all nuclei within the 
germarium, it gets highly enriched in the germinal vesicle within the oocyte during egg 
chamber development until stage 12, and disappears again later concomitant with germinal 
vesicle breakdown at the start of the first meiotic division. Surprisingly, we find that Cyclin J 
is not required for female fertility. Chromosome segregation during female meiosis as well as 
the rapid early embryonic cell cycles after fertilization occurs normally in the complete 
absence of Cyclin J. Only a slight increase in the number of embryos that do not develop 
beyond cycle 1 is noticeable when averaging over many collections from CycJ-deficient 
females. 
   Most of our results are at variance with those published earlier (Finley Jr. and Brent, 1994; 
Kolonin and Finley, 2000). Based on the described yeast two hybrid and co-
immunoprecipitation experiments, Drosophila Cyclin J for instance was suggested to prefer 
Cdk2 over Cdk1 as a partner kinase. Curiously, in these same yeast two hybrid experiments, 
Drosophila Cyclin E was also observed to have the opposite preference from what we have 
observed in vivo (Finley Jr. and Brent, 1994; Knoblich et al., 1994). In case of the published 
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co-immunoprecipitation experiments (Kolonin and Finley, 2000), a cross reaction of the 
affinity-purified rabbit antibodies against Cyclin J with a protein of similar molecular might 
have compromised the validity of these earlier conclusions. Concerning the validity of our 
present discordant conclusions, we emphasize that we cannot exclude the possibility that the 
EGFP fusions, which we have studied, do not behave like the untagged endogenous Cyclin J. 
We consider this possibility to be unlikely, as we have obtained consistent results with EGFP 
fused at either the N- or the C-terminus of Cyclin J. Moreover, experiments with other cyclins 
have clearly demonstrated that EGFP extensions do not affect their function (Buszczak et al., 
2007; den Elzen and Pines, 2001; Hagting et al., 1998; Jackman et al., 2002). Finally, our 
finding that progression through the syncytial cycles of early Drosophila embryogenesis is 
not noticeably affected by the complete absence of Cyclin J is entirely independent of 
assumptions concerning the functionality of our Cyclin J fusions. The severe mitotic defects 
reported to occur after injection of antibodies or aptamers against Cyclin J (Kolonin and 
Finley, 2000) might reflect cross-reactions or indicate that the binding of these reagents to 
Cyclin J has other consequences than eliminating Cyclin J altogether.  
   The absence of obvious phenotypic abnormalities after complete elimination of CycJ 
function might indicate functional redundancies. Our preliminary evidence argues against the 
suggestion that it is the function of Cyclin A, B, B3 or E which masks a Cyclin J requirement. 
Our failure to prevent the characteristic CycA zygotic effect mutant phenotype by expression 
of Cyclin J fusions with EGFP in embryos argues against major functional overlap between 
Cyclin A and Cyclin J. In addition, a reduction of the number of functional CycA, CycB, 
CycB3 or CycE gene copies in CycJ-deficient females using multiple strong or null alleles did 
not consistently reduce their fertility or affect progression through the syncytial cycles in 
progeny. Moreover, genetic elimination of CycJ in females with reduced CycE function did 
not further reduce their compromised fertility. Future unbiased genetic screens in our CycJ-
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deficient background might lead to an identification of components acting redundantly with 
Cyclin J. 
   Redundant functional pathways might also explain that some metazoans like C. elegans 
appear to have lost Cyclin J and that the expression pattern of Cyclin J varies in different 
metazoan lineages. In contrast to Drosophila Cyclin J, which appears to be expressed 
exclusively in the female germline, the human Cyclin J paralogs are much more widely 
expressed in various somatic tissues according to the tissue distribution of the expressed 
sequence tags. The apparent somatic expression in humans, as well as the presence of a 
Cyclin J homolog in the choanoflagellate Monosiga brevicollis, clearly argues against the 
notion that the primordial Cyclin J function is oogenesis-specific.  
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Figure legends 
 
Figure 1. Cyclin J homologs in metazoans.  
A tree based on predicted amino acid sequences illustrates that Cyclin J homologs are 
encoded in unicellular flagellate and metazoan genomes. A duplication resulting in Cyclin J 
(J) and Cyclin J-like (Jl) has occurred in mammals. Apart from Cyclin J sequences, additional 
cyclins of the A-, B-, D- and E-type families were included. Ag: Anopheles gambiae; Dm: 
Drosophila melanogaster; Hs: Homo sapiens; Mb: Monosiga brevicollis; Mm: Mus musculus; 
Nv: Nematostella vectensis. 
 
Figure 2. EGFP-Cyclin J expression during oogenesis. 
Ovaries from females with gEGFP-CycJ III.16 resulting in expression EGFP-Cyclin J under 
control of the CycJ regulatory region were fixed and labelled with a DNA stain. (A) ovariole 
with early stages of oogenesis (germarium until stage 10). (B) stage 12. (C-E) germarium. (F-
H) stage 4. (I-K) germinal vesicle region of a stage 12 oocyte. (L-N) region with metaphase I 
figure of a mature stage 14 oocyte. Bars in A and B correspond to 30 and 100 μm, 
respectively. All other bars correspond to 10 μm. 
 
Figure 3. Cyclin J-EGFP levels during oocyte maturation. 
Oocytes from gCycJ-EGFP II.6 females at either stage 12 or stage 14 were analyzed by 
immunoblotting for the presence of Cyclin J-EGFP using antibodies against GFP (anti-GFP, 
upper panel). Apart from Cyclin J-EGFP, this antibody detects a second band (see asterisk) 
which is also observed in control ovaries that do not express GFP (data not shown). An anti-
PSTAIR peptide antibody, which reacts predominantly with Cdk1 in Drosophila was used as 
an additional loading control (anti-Cdk1). The number of loaded oocytes is indicated on top of 
lanes 1-4. The position of molecular weight markers is indicated on the right side. 
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Figure 4. Cyclin J is a Cdk1 partner. 
Panel A: Proteins immunoprecipitated with antibodies against GFP from ovary extracts (E) of 
either gcal1-EGFP (Cal1-EGFP) and gCycJ-EGFP (CycJ-EGFP) females were analyzed by 
immunoblotting with anti-GFP, anti-Cdk1 and anti-Cdk2. Cdk1 but not Cdk2 could be 
detected in the CycJ-EGFP immunoprecipitates (IP). The long exposures shown for maximal 
anti-Cdk2 sensitivity reveals some non-specific reactions in the extracts apart from the 
reaction with Cdk2 (arrowhead). The absence of Cdk1 in the control Cal1-EGFP 
immunoprecipitate (IP) indicates that the interaction of Cdk1 with CycJ-EGFP is specific. The 
presence of multiple bands after immunoblotting with anti-GFP presumably reflects 
proteolytic degradation. The position of molecular weight markers is indicated on the right 
side. . 
Panel B and C: The binding preference of EGFP-Cyclin J and Cyclin J-EGFP for Cdk1-myc 
or Cdk2-myc was analyzed after coexpression in embryos using the UAS/GAL4 system. 
Panel B: Extracts of embryos expressing Cdk1-myc and/or Cdk2-myc as indicated above the 
lanes were analyzed by immunoblotting with anti-myc and anti-PSTAIR (anti-Cdk1) which in 
Drosophila detects almost exclusively Cdk1. Probing with anti-myc demonstrates that Cdk1-
myc and Cdk2-myc have a distinct electrophoretic mobility and are expressed at equal levels. 
Anti-PSTAIR reveals equal loading. Panel C: After coexpression of EGFP-Cyclin J or Cyclin 
J-EGFP with Cdk1-myc and Cdk2-myc, the former but not the latter was co-
immunoprecipitated with antibodies against GFP, as revealed by immunoblotting with anti-
myc (α-myc). Moreover, the endogenous Cdk1 but not the endogenous Cdk2 was co-
immunoprecipitated as well, as revealed by immunoblotting with either mouse anti-PSTAIR 
(anti-Cdk1) or rabbit anti-Cdk2. These antibodies also detected the myc-tagged versions. 
However, the corresponding region is not shown in case of the anti-Cdk2 immunoblot 
because the reaction with Cdk2-myc was obscured in the immunoprecipitates by a strong 
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signal caused by commigrating heavy chains from rabbit anti-GFP used for 
immunoprecipitation.  
 
Figure 5. Cyclin J-EGFP is stable during M and G1 and cannot replace Cyclin A. 
Sibling embryos with (CycA+, A-F) or without (CycA-, G-L) zygotic Cyclin A expression 
which either did not express Cyclin J-EGFP (A-C, G-I) or expressed it (D-F, J-L) were 
collected for 1 hour and aged to the stage where the cells in the dorsal epidermis (above the 
hatched horizontal lines) are in G1 of cycle 17 and those in the ventral epidermis (below the 
hatched horizontal line) in G2 or M of cycle 16 during normal development. Progression 
through mitosis 16 does not occur in CycA- embryos and therefore all epidermal cells remain 
in G2. prd-GAL4 drives expression on the left of the hatched vertical line in the epidermal 
regions shown after labelling with antibodies against Cyclin A (CycA), Tubulin (Tub) and a 
DNA stain (DNA). In contrast to Cyclin A, Cyclin J-EGFP is not degraded during mitosis 16 
and G1 of cycle 17. Moreover, Cyclin J-EGFP cannot prevent the cell cycle arrest in G2 of 
cycle 16 when expressed in CycA- embryos. Bar corresponds to 10 μm. 
 
Figure 6. Genetic elimination of Cyclin J. 
Panel A: The genomic region with CycJ and the neighbouring genes eIF5B, armi, CG14971 is 
illustrated schematically. Start sites and direction of transcription are indicated by arrows. 
Exons are represented by boxes with black filling indicating coding regions. Flp-mediated 
recombination between FRT sites present within the transposons PBAC{RB}e01160 and 
P{XP}d0735 (insertion sites indicated by triangles) resulted in the deficiency Df(3L)AJ14. 
Genes deleted by Df(3L)AJ14 were re-introduced by transgenes (garmi, gCycJ, gCG14971) 
carrying genomic fragments including the genes armi, CycJ or CG14971, respectively, as 
indicated by the black horizontal lines. Moreover, the position of additional transposon 
insertions (P{wHy}CycJDG29702 and PBac{5HPw+}CycJA138) in CycJ are indicated by triangles. 
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Panel B: The presence of the expected Flp/FRT-induced deletion was verified by PCR assays 
using genomic DNA isolated from flies which were homozygous for Df(3L)AJ14 
(Df(3L)AJ14) or carried Df(3L)AJ14 over a balancer chromosome (Df(3L)AJ14/Bal). Primer 
pairs amplifying the recombined hybrid RB-XP transposon (RB-XP), or fragments from the 
genes eIF5B (eIF5B), armi (armi) or CG14971 (CG14971) were used in parallel reactions. 
These primers did not amplify products when used without template DNA (no DNA).  
Panel C: Genomic DNA was isolated from flies which carried Df(3L)AJ14, garmi III.8, 
gCG14971 III.10 either over a balancer chromosome (ΔCycJ/Bal) or homozygously (ΔCycJ). 
A duplex PCR with primer pairs amplifying fragments from the armi and CycJ genes 
confirmed the absence of CycJ in the flies homozygous for Df(3L)AJ14, garmi III.8, 
gCG14971 III.10. 
Panel D: Df(3L)AJ14, garmi III.8, gCG14971 III.10 embryos which completely lack maternal 
and zygotic CycJ function were fixed during the syncytial stages and labelled with a DNA 
stain. Spacing and appearance of nuclei during interphase (inter) and during mitotic pro- 
(pro), meta- (meta), ana- (ana), and telophase (telo) was observed to be indistinguishable from 
wild type controls (not shown). 
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Table 1. Viability and fertility of flies without CycJ, armi or CG14971 
Genotype Viabilitya) Fertilityb) 
  Female Male
w1 n.d.c) 100 100 
CycJDG29702/CycJDG29702 n.d.d) 102 n.d. 
CycJDG29702/Df(3L)AJ14 n.d.d) 113 n.d. 
CycJDG29702/Df(3L)Exel6095 n.d.d) 110 n.d. 
Df(3L)AJ14/Df(3L)AJ14, garmi III.8, gCG14971 III.10 122 111 140 
gCycJ II.41/+; Df(3L)AJ14/Df(3L)AJ14, garmi III.8, gCG14971 III.1 124 115 163 
Df(3L)AJ14/Df(3L)AJ14, garmi III.8 114 90 120 
Df(3L)AJ14/Df(3L)AJ14 97 0   29 
 
a) Progeny flies with the listed genotypes as well as balanced siblings eclosing from the same 
cross were counted (n > 300). The fraction of progeny with the listed genotype was calculated 
and expressed in percent of the fraction predicted in case of full viability.  
b) Parallel crosses (3-4 for each genotype) with a fixed number of either test females or test 
males were crossed with the same number w1 flies. The total number of progeny was counted 
and expressed in percent of the number of progeny obtained with the w1 control crosses (n = 
1324). 
c) n.d., not determined 
d) Although not precisely quantified, the viability appears to be normal. 
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Supplementary Table 1: Proteins co-immunoprecipitated with CycJ-EGFP 
 
Immunoprecipitates isolated with anti-GFP from ovary extracts of either gCycJ-EGFP II.6 or 
gCal1-EGFP II.1 females were resolved by gel electrophoresis. Thereafter the gel lanes were 
cut from top to bottom into 15 slices, each of which was digested with trypsin before MS/MS 
analysis of the resulting peptides using the MASCOT search engine 
(www.matrixscience.com). The table includes all Drosophila proteins for which at least one 
peptide with either an ion score of >40 or an expect value of <10-4 was detected. For each gel 
slice, the identified proteins are ordered from top to bottom according to the number of 
different peptides detected with the protein revealed by the maximal number of detected 
peptides on top. Proteins which were observed in both immunoprecipitates (CycJ-EGFP and 
Cal1-GFP control) and thus appear to represent non-specifically associated contaminants are 
marked in green. Cdk1/Cdc2 which is marked in red was only detected in the CycJ-EGFP 
immunoprecipitate. The other proteins that were only detected in the CycJ-EGFP 
immunoprecipitate are in general highly abundant proteins (like ribosomal proteins) and some 
of these have been detected as contaminants in earlier co-immunoprecipitation experiments 
(unpublished observations). None of these proteins is a protein kinase family member. 
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Supplementary Figure 1: Progression through the syncytial division cycles in CycJ-
deficient embryos heterozygous for mutations in other cyclin genes 
 
Embryos were collected from females that either had one copy of the CycJ gene 
(Df(3L)AJ14/+) or none (Df(3L)AJ14/ΔCycJ = Df(3L)AJ14, garmi III.8, gCG14971 III.10). 
In addition, these females had either two functional copies of other cyclin genes (+/+) or only 
one functional copy of a particular cyclin gene in trans over a mutant allele (CycAneo114/+, 
CycAC8LR1/+, CycB2/+, CycB3/+, CycB33/+, CycEAR95/+, or CycEpz5/+). After one hour of egg 
collection, one half was fixed immediately (red bars) while the other half was aged for an 
additional hour at 25°C before fixation (blue bars). The embryos were stained with a DNA 
stain and staged microscopically (n > 200 for each genotype). The bar diagram displays the 
fraction of embryos which were found to be at a developmental stage either before mitosis 1 
(before M1), during cycles 1-4 (1-4), 5-9 (5-9), 10-13 (10-13), interphase 14 (I14), or after 
onset of mitosis 14 (>M14). The fraction of embryos with abnormal phenotypes like 
chromatin bridges during anaphase and telophase or irregular spacing of nuclei or mitotic 
figures was found to be below 3% for all of the analyzed genotypes. The embryos in the aged 
collections obtained from CycJ-deficient females which were before M1 (blue bars marked by 
asterisks) represent either unfertilized embryos or fertilized embryos which have failed to 
develop beyond completion of female meiosis. Since their fraction appeared to vary 
extensively for the different genotypes, we evaluated two additional independent collections 
and noted a surprisingly poor reproducibility. The average obtained for the three collections 
(+/- s.d.) is given on the right side. In particular, the high fractions of embryos before M1 
observed with some of the CycJ-deficient female genotypes (first, second and sixth row from 
the top) could not be confirmed in these additional experiments.  
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